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Abstract
Choroid plexus (CP) produces the cerebrospinal fluid (CSF) that fills the ventricles and 
subarachnoidal space, and infiltrates the intercellular spaces of CNS parenchyma. CP 
transplantation enhances axonal outgrowth in the spinal cord lesion. Cultured choroid 
plexus epithelial cells (CPECs) secret neurotrophic factors into the medium.  CP undergoes 
cytological changes in diseases uch as Alzheimer and Huntingon's disease. The ischemia-
injured infraction due to middle cerebral artery occlusion is suppressed by transplantation 
of CPECs into the CSF in the rat. Allo- or xenotransplantation f encapsulated  CP has been 
studied for the treatment of experimental Huntington's disease.  CP can be regarded as the 
neurotrophic center of the CNS, regulating and maintaining the normal brain function via 
CSF.
Key  words  : trophic function, nerve protection, transplantation, culture, in situ  hybridiza-
tion
Introduction
 The choroid plexus (CP) is located in ventricles, 
including lateral, third and fourth ventricles. The 
 CP is composed of a simple epithelium and 
underlying connective tissue. The choroid plexus 
epithelial cells (CPECs) are a continuation of the 
ventricular ependymal cells, and the connective 
tissue is part of pia mater covering the surface of 
the cerebral hemisphere. CPECs are modified 
ependymal cells having basal laminae at the basal 
side facing the pia mater. Unlike the ventricular 
ependymal cells having many cilia on the ventric-
ular surface, CPECs have only occasional cilia, 
instead, they have numerous microvilli on the 
ventricular surface. CPECs contain numerous 
mitochondria in the cytoplasm. Numerous clear 
vesicles are located in the apical zone of the 
cytoplasm (Fig. 1). 
 Originally CPECs are the neural epithelium of
the neural tube that produces the cerebral 
parenchyma in development. The neural  epithe-
lium of the neural tube changes into ependymal 
cells after ceasing the production of the cerebral 
parenchymal tissues, while that of the CP remains 
as a single cell layer without producing any 
cerebral parenchyma in development. Therefore, 
CPECs form a simple epithelium directly contact-
ing with the pia mater. The pia mater at the CP is 
highly vascularlized, with numerous sinusoidal 
blood vessels beneath the CPEC basal lamina. 
 The CP is the tissue responsible for producing 
the cerebrospinal fluid (CSF). The CSF volume is 
80-150 ml in human, and the volume of the newly 
produced CSF is approximately 500 ml per day. 
In rats, considering the difference in body weight, 
the CSF volume might be 400-750 1, and the new 
production might be 2.5 ml per day. The turnover 
of CSF is approximately 3-4 times per day, taking 
6-8 h for one turnover in rats. Younger rats take
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 Choroid plexus of the rat 4thventricle. The choroid plexus consists of epithelial cells and underlying connective tissue containing an
blood vessels. The connective tissue is a continuation of  pia mater covering the surface of cerebral hemisphere. Scale bar: 50  um
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shorter time (2-3 h) for one turnover. In human, 
CSF production rate is 0.41  ml/min at  28 years of 
age, and 0.19  ml/min at 77 years (Preston et al, 
2001). The CSF contains lower concentration of 
glucose, potassium, calcium bicarbonate and 
amino acid than blood. In contrast, sodium, 
chloride, magnesium and folate are maintained at 
a higher concentration than in blood. Trans-
thyretin is one of the most abundant proteins of 
the CSF. The rich vasculature in the CP is 
needed to supply a sufficient amount of blood for 
the production of CSF (Serot et al. 2003). 
 The CP has been extensively studied from the 
point of view of CSF production. The CSF flows 
through the ventricles and fills the subarachnoidal 
space. Considering that the CSF infiltrates the 
intercellular spaces of neurons and glial cells, CSF 
plays a critical role in maintaining the normal and
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regular function of neurons and glial cells in the 
CNS. This indicates that the CP, as the CSF-
producing organ, plays an important role in 
regulating the functions of neurons and glial cells. 
The CSF  components are directly related to the 
conditions of the neural tissues of CNS. Bioactive 
molecules, which include neurotrophic factors 
play an important role in maintaining neural 
tissues and in regulating their normal functions in 
the CNS. 
 Regarding the functions of CP and CPECs, 
Chodobski and Szmydynger-Chodoboska, (2001) 
described that choroidal expression of several 
polypeptides is observed during brain develop-
ment and in various CNS disorders, including 
traumatic brain injury and ischemia. It is 
proposed that the CP plays an integral role not 
only in normal brain functioning, but also in the
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recovery from injury. In the same respect, 
Johanson and Palm (2000) described as follows:  "Mammalian CPECs synthesize and secrete to 
regions of the cerebroventricular system many 
growth factors and other peptides that are of 
trophic benefit following injury. For example, 
several growth factors are upregulated in choroid 
plexus after ischemic and traumatic insults to the 
CNS. The presence of numerous types of growth 
factor receptors in choroid plexus allows growth 
factor mediation of recovery processes by auto-
crine and paracrine mechanisms." 
 In this article, we will present various kinds of 
 CP functions in terms of neurotrophic effect in the 
CNS, and  CP responses to changes in neurodege-
nerative diseases and traumatic injuries.
CPECs
sion
have a strong effect on neurite exten-
 First, we examined neurotrophic functions of 
CPECs in vivo and in vitro. The first in vivo 
experiment was performed in 2001. In this 
experiment, the  CP was transplanted into the 
injured spinal cord of a rat (Ide et al. 2001). The 
 CP was minced into small fragments before 
transplantation and engrafted into the dorsal 
funiculus of the spinal cord at the C2 level. 
Several days later, it was found that numerous 
regenerating axons had extended into the graft 
(Fig. 2). Electron microscopy and immunohisto-
chemistry showed that growing axons were 
intimately associated with grafted  CPECs. In 
order to know whether growing axons extending 
in the caudo-rostral direction within the lesion 
derived from the dorsal root or from intirinsic 
spinal cord neurons, immunohistochemistry for 
CGRP (calcitonine-gene related polypeptide)  -
positive fibers were performed, since CGRP is a 
marker for the sensory axons coming from the 
dorsal roots.  CGRP-positive axons were  con-
tained in the growing axons, being partly in 
contact with engrafted  CPECs. Similarly, HRP 
that had been injected into the sciatic nerve 
labeled growing axons within the lesion. 
Numerous axons were labeled, and some of them 
further extended beyond the rostral border of the 
lesion. This study revealed for the first time that 
the  CP, if grafted into the spinal cord, has a unique 
function of enhancing axonal regeneration of 
sensory nerves. The findings of this study 
suggest that the  CPECs might exert neurotrophic 
functions by secreting some diffusible molecules, 
and/or might express specific adhesion molecules 
on the cell surface.
Choroid plexus
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Fig. 2
One month after grafting of choroid plexus into the rat cervical spinal 
cord. The  choroid plexus was minced into small fragments before 
grafting. Grafted choroid plexus is faintly stained in the background, 
and regenerating axons are clearly seen as whitish strings. In the 
original micrograph, choroid plexus was stained red, while regenerat-
ing axons were green. There are numerous regenerating axons, many 
of which are in close association with the choroid plexus. Scale bar: 50 
This  micrograph shows the interaction of choroid plexus with 
astrocytes. Choroid plexus was originally stained red, and astrocytes 
are green. It is shown that choroid plexus are interacted with 
astrocytes. Scale bar: 50  um 
This micrograph was obtained from the spinal cord in which freeze-
treated choroid plexus was grafted. No choroid plexus remained in the 
spinal cord. Scale bar: 100  um
(from Ide et al.,2001)
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 In order to address these problems, we next 
performed an in vitro experiment to examine 
whether the CPECs have specific adhesion 
molecules on the cell surface that enhance axonal 
outgrowth (Chakrabortty et al. 2000). CPECs of 
the 4th ventricle of mice were cultured in a 
monolayer. Neurons were isolated from the 
dorsal root ganglia of newborn mice, and co-
cultured on the monolayer culture of CPECs. It 
was demonstrated that neurons from dorsal root 
ganglia extended many long neurites with elabo-
rate branches on the surface of CPECs. The total
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length of neurites per neuron was compared with 
that of neurons co-cultured on astrocytes or 
cultured on the laminin-coated plates. The 
neurite length was much greater when neurons 
were co-cultured with CPECs than when cultured 
on astrocytes or on the laminin-coated plates. It 
was impressive to see neurons extending long 
neurites with branches on the surface of CPECs in 
vitro (Fig. 3). 
 Neurons used in this study were peripheral 
ones derived from dorsal root ganglia. Consider-
ing that the  CP has influences primarily on the
Fig. 3 Comparison of neurite outgrowth from dorsal root ganglion neurons cultured in the following different conditions
A: The culture on the laminin substrate. Neurites are relatively short and straight, and branching with clear-cut angles.  B
: The culture on the astrocyte monolayer. Neurites are longer and with more branches than on the  laminin substrate. 
C: The culture on the choroid plexus epithelia cell monolayer. There are elaborate neurite extensions from a neuron on a choroid plexus 
  epithelial cell. Neurites are thicker and longer with more branches than on the astrocyte monolayer. Scale bar: A-C, 50  um 
D and E: Scanning electron micrographs of neurite outgrowth from the dorsal root ganglion neurons on choroid plexus epithelial cells.
The tip of growing axon has a growth cone (C) with several long filopodia (arrows).
the surface of the choroid plexus epithelial cells.
There are many microvilli (arrowheads) on
Scale bar: D, 6  um;  E, 5  um 
(from Chakrabortty et al., 2004)
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CNS neurons, we performed an experiment 
similar to the one above by using hippocampal 
neurons. Neurons were obtained from hippocam-
pus of embryonic day-18 mice, and co-cultured on 
the monolayer of CPECs. For comparison, 
hippocampal neurons were co-cultured with 
astrocytes or cultured on the poly-L-lysine  (PLL)- 
coated dishes (Kimura et al, 2004). In this 
experiment, the cultured CPECs in monolayer 
were treated with ethanol before co-culturing 
with hippocampal neurons. This treatment is 
done to kill CPECs, and thus eliminate the 
influence of molecules secreted into the culture 
medium by living CPECs. This in vitro experi-
ment demonstrated that CPECs have an ability to 
enhance the outgrowth of neurites from neurons 
that were attached to the surface of CPECs. It
Choroid plexus
was shown that CPECs expressed N-CAM, N-
cadherin, laminin, fibronection and p75 (a low 
affinity neurotrophin receptor) on their surface. 
In addition, N-cadherin is expressed on the CPECs 
at the site of contact between CPECs and neurites 
(Fig. 4). These in vitro studies show that CPECs 
produce specific molecules, including cell adhesion 
molecules, extracellular matrix components and 
receptors of neurotrophic molecules on the cell 
surface. 
 As the next step, we examined the effect of 
conditioned medium of cultured CPECs. The CP 
was obtained from the lateral and 4th ventricle of 
4-week-old rats, and cultured in a monolayer for 
12 days according to the method by Zheng and 
Zhao (2002). In parallel, neurons from the 
hippocampus were cultured for 24 hours in the
Fig. 4  Hippocampal neurons were cultured on the choroid plexus epithelial cells in rat
A: Neurons were stained for  B-tubulin III, and choroid plexus epithelial cells were stained for the N-cadherin cell-cell adhesion molecule. 
  Choroid plexus epithelial cells are seen in the background, and two neurons are seen as whitish bodies. Scale bar: 100  um 
B: Neurites and choroid plexus epithelial cells were cut perpendicular to the culture dish. Cadherin is immunohistochemically marked 
 with gold particles. There is cadherin (arrowheads) at the attachment between neurites (N) and choroid plexus epithelial cell (E). 
  Filopodia extend from neurite along the surface of choroid  plexus epithelial cell. Scale bar:1um
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 neurobasal medium (NB) or in the neurobasal 
supplemented with B27 (NB/B27). The condi-
tioned medium of the CPEC culture was prepared 
and added to the culture of hippocampal neurons. 
Neurons were fixed 24 hours after treatment, and 
the neurite extension was measured. The longest 
neurite length and the individual neurite lengths 
were greater in the conditioned medium than in 
the control. This experiment demonstrated that 
the conditioned medium enhanced neuron surviv-
al and neurite extension (Watanabe et al. 2005). 
Immunohistochemistry showed that CPECs ex-
press trophic factors, including HGF, IGF-II, 
bFGF, and NT-4. It is considered that many kinds 
of trophic factors might work in a synergistic 
fashion for the survival of neurons  and for neurite 
extension from neurons. However, any antibodies 
against these trophic factors suppressed neither 
the survival nor the neurite extension activity of 
neurons in vitro.
 CPEC
 age  of the  brain
rescues ischemic dam-
 The effect of CPECs on ischemic injury in vivo 
was examined in the transplantation experiment, 
in which the middle cerebral artery (MCA) of rat 
was occluded to produce ischemic lesions in the 
rat brain, followed by injection of CPECs into the 
CSF via the 4th ventricle (Matsumoto et al. 2010). 
This experiment showed that CPEC transplanta-
tion markedly reduced the ischemic area of the 
brain. The occlusion of the middle cerebral artery 
(MCAO) was performed using a 4-0 nylon 
monofilament with, at the tip, a small paraffin ball 
approximately 0.25 mm in diameter. The monofi-
lament was inserted from the external carotid 
artery (ECA) into internal carotid artery (ICA), 
and advanced cranially until the advancement of 
the filament was resisted at the origin of the MCA 
from the common carotid artery (CCA). In this 
way, the MCA was occluded with the paraffin ball 
located at the tip of the monofilament. Thirty 
minutes after occlusion, cultured CPECs (6x106) in 
60  l of Hanks' balanced salt solution (HBSS) was 
stereotaxically injected into the 4th ventricle 
through the hole made at 3.8 mm caudal to the 
lambda suture in the midline of the skull. Thirty 
or 90 minutes later, the MCA was reperfused by 
removing the monofilament. The MCA perfusion 
area of the brain was kept in an ischemic condition 
for 60 to 120 minutes before reperfusion. For cell 
culture,  CP tissues were excised from the lateral 
and 4th ventricles of 4-week-old rats, dissociated 
with pronase, and cultured in DMEM containing
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fetal bovine serum. Five days later, the medium 
was changed for serum-free DMEM, and after 
culturing for an additional 7 days, cells were used 
for transplantation. Cultured CPECs expressed 
trophic factors, including bFGF, NT-4, HGF, and 
GDNF. 
 For the measurement of infarction volume, 
coronal sections (1.5-mm-thick) of the brain  were 
stained with 2 % solution of 2, 3, 5  -tripheny-
ltetrazolium chloride (TTC) for 20  min. The 
infarction volume was calculated by multiplying 
the infarcted areas by the depth of the infarction 
and presented as a ratio to the volume of the 
corresponding contralateral cortex or striatum. 
 The infarcted area is demonstrated as the TTC-
negative area. Rats of the CPEC-transplanted 
group with reperfusion after 60  min of ischemia 
had smaller infarcted areas in the stratum (43% 
versus 70%) and cerebral cortex ( 9 % versus 33%) 
than those of the vehicle-injected group. Simi-
larly, rats of the CPEC-transplanted group with 
reperfusion after 120  min had smaller infarcted 
areas in the sriatum (60% versus 80%), and 
cerebral cortex (35% versus 70%) than those of the 
vehicle-injected group (Fig. 5). 
 Behavioral assessment was performed 24 hours 
after MCA occlusion using the neurological 
severity score (6-point scale). Neurological out-
come in the CPEC-transplanted group was 2.7 
versus 1.2 points in the  60-min MCA occlusion rat, 
and 3.5 versus 2.4 points in the  120-min MCA 
occlusion, compared to those of the vehicle-in-
jected rats. 
 TUNEL-positive apoptotic ells were decreased 
in number in the cerebral cortex in the CPEC-
transplanted group. The proportion of caspase  3-
positive cells in the cerebral cortex was decreased 
in the CPEC-transplanted group (14.0% versus 
5.4%). 
 CPEC injection up-regulated several molecules 
including CREB (cAMP response element binding 
protein) and  bcl-2, while down-regulating  IL-1 
 (interleukin-1  ), iNOS, and TNF (tumor necrotic 
factor  )  . There was extensive infiltration of  OX-
42 positive cells in the cerebral cortex in vehicle 
injected rats, while the CPEC injection distinctly 
decreased the number of OX-42 cell in the brain 
including cerebral cortex and corpus callosum. 
These CPEC functions of anti-apoptotic proper-
ties and the suppression of proinflammatory 
molecules contributed to the cell survival in the 
ischemia-injured brain tissue. 
 Transplanted cells were located within the 
lateral and 4th ventricles and on the brain surface. 
No transplanted CPECs were found at the sites of
 38
(A)  60-min MCAO
IDE et al: Choroid plexus
(C)  120-min MCAO
Vehicle + CPECs Vehicle  +  CPECs
Fig. 5
Rat MCA was occluded for 30  min before injection of BMSCs (5  X  106.  60ul  in  HBSS) into the 4th ventricle. Rats were re-perfused after 30  min or 90  min 
(i.  e., 60 or 120  min after induction of ischemia). Twenty-four hours after ischemia, the brain was obtained and sectioned into thin coronal sections. 
These coronal brain slices were stained with TTC. The infarction volume was markedly reduced in rats with CPEC transplantation (A and C) 
Representative TTC-stained sections from the vehicle injected group and the CPEC-transplanted group 24 h after  60-min MCAO (A) and  120-min 
 MCAO (C). The white regions of the brain are infracted areas. (B and  ID) Infarction volumes are significantly smaller in CR\EC-transplanted ratsthan 
in vehicle-injected rats, both in the striatum and cerebral cortex  (*p  <  0.01). (E and F) Neurological deficits 24 hours after MCAO by 6-point scale 
method. Open and closed circles the neurological scores of rats from the vehicle-injected and CPEC-transplanted group, respectively.  *p  <  0.01.  **p  <0. 
05 (from Matsumto et al., 2010)
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ischemic injury. This suggests that transplanted 
CPECs did not migrate to the infracted area to 
rescue neural cells therein, but exerted their 
effects by releasing diffusible factors that reached 
the lesion through the CSF.
Specific molecules produced in the CPECs
 Matsumoto et al. (2003) isolated genes predomi-
nantly expressed in the mouse CP using suppres-
sion subtractive hybridization. By subtraction 
with cerebral cortex cDNA, transthyretin and 
transphsophodiesterase 1a were predominant in 
the adult mouse CP. 
 In other experiments, cDNA derived from the 
 CP of neonatal (postnatal day 5) mice was 
subtracted with cDNA from adult mouse CP. In 
this way, 49 complimentary DNA (cDNA) frag-
ments were isolated, in which 43 were known 
sequences in the data base, and the remaining 6 
were novel. The expression of these genes in 
CPECs was examined using RNA blots and/or in
situ hybridization, and the abundant expression of 
gelsolin, phospholipid transfer protein (PLPT) 
(Fig. 6), ATP-binding cassette transporter sub-
family A member 8 (ABCA8), androgen-inducible 
aldehyde reductase (AIAR), and Na/sulfate co-
transporter  SUT-1  was confirmed. One novel 
gene (FS 88) was expressed in the CP from 
neonatal mice. These findings indicate that CP is 
involved in the such processes as prevention of 
fibrillization of amyloid  B protein (transthyretin 
and gelsolin), and lipid metabolism (PLPT and 
ABCA 8) and detoxication (AIAR). 
 Gonzalez et al. (2011) reported that augulin is 
secreted by CPECs. Augulin is the protein 
encoded by Ecrg 4 (esophageal cancer-related 
gene) known as a tumor-suppressor gene. When 
augurin is increased, the cancer proliferation is 
suppressed, and, therefore, the production of 
augurin is usually kept at a low level in the 
proliferative cancer. In their paper, Gonzalez et 
al. describe the results as follows:  The CPECs 
are the major source of Ecrg4 in the CNS, and
 Fig. 6
These micrographs how the expression of phospholipids transfer protein (PLTP) in CPECs. Sagittal (A, D, E) or coronal (B, C) sections of the brain 
were shown, and CP in the 4th ventricle (A), lateral ventricle (B) and  3rd ventricle (C) were stained by in situ hybridization. The CP in (A) was magnified 
in (D), and a part of the CP in (D) was further enlarged in (E). mRNA expression was detected by in situ hybridization. The expression of mRNA of 
PLTP is restricted to the epithelial cells, with no hybridization at the underlying connective tissues. Scale bar: 200 um 
(from Matsumoto et al., 2003)
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Ecrg 4 mRNA is predominantly localized to 
CPECs, ventricular and central canal ependymal 
cells. After a stab injury into the brain, both 
augurin staining and Ecrg 4 gene expression 
decreased  precipitously." Based on the results, 
they concluded as follows:  "An unusually elevated 
expression of the Ecrg4 gene in the CPECs 
implies that its product augurin plays a role in CP-
CSF-CNS function. The results are all consistent 
with a model whereby an  injury-induced ecrease 
in augurin dysinhibits target cells at the 
ependymal-subependymal  interface." They spec-
ulate that the ability of CPECs and ependymal 
cells to alter the progenitor cell response to CNS 
injury may be mediated in part by Ecrg 4. 
 CPECs are characterized by containing a high 
concentration of transthyretin (TTR). Therefore, 
TTR is a reliable immunohistochemical marker 
for CP. TTR is a binding protein of  thyroxine  (T4) 
and retinol (vitamin A). The name  "transthyre-
tin" comes from the property of binding thyroxine 
and retinol. TTR is synthesized also in the liver. 
The fact that CPECs produce a large amount of 
TTR at the site of the blood-CSF barrier means 
that CP might play an important role in transport-
ing T4 and retinol from the blood flow into the 
 CSF. TTR is also related to the detoxification of 
the CSF by binding toxins, including PVB. TTR is 
also important in keeping the protein in a normal 
condition. Abnormal proteins change into  amy-
loid   , which is in most cases deposited in the 
brain parenchymal tissue, thus causing 
Alzheimer's disease. TTR function as detoxifica-
tion by binding abnormal protein to remove it 
from the CNS. This indicates that TTR is 
profoundly related to the development of 
Alzheimer's disease.
 C horoid plexus in  diseases
 The CP tissues underwent varying kinds of 
changes in many diseases including Alzheimer's 
disease (Serot et al. 2003), and amylotrophic 
lateral sclerosis (Uchino et al. 1994). In 
Alzheimer's disease, CPECs become atrophic, i. e., 
epithelial cells decrease in height and contain a 
large number of lipofuschin vacuoles. The basal 
lamina of the epithelial cells becomes irregular 
and thickened. Microvilli are thickened, and their 
stroma become fibrotic. The wall of vessels 
becomes thick, and there are deposits of IgG and 
 IgM along the epithelial basal lamina. These 
features suggest the decrease of functional 
capacities of CPECs, leading to the delayed 
turnover of CSF. The CSF turnover rate is
Choroid plexus
usually 6-8 h, however, it becomes delayed to 36 h 
in Alzheimer's disease (Serot et al. 2003). The 
level of CSF transthyretin in ALS is lower than 
normal. Transthyretin, which is contained abun-
dantly in CPECs, is normally associated with 
amyloid protein to form complexes to inhibit 
amyloid protein from undergoing fibrillotransfor-
mation (Serot et al. 1997). In rats, the clearance of 
intraventricularly injected amyloid   is 10.4 /min 
at 3 months of age, and it is 0.71  l /min at 30 
months of age. This means that the brain content 
of amyloid peptide increases in the CSF of old 
animals (Preston, 2001). In addition, vitamin B12 
and folate were decreased in CSF of old animals, 
implying the down-regulation of methylation 
process of phospholipids, nucleic acids, catechol-
amine, and acetylcholine in the CNS of aged 
animals (Ikeda et al. 1990; Serot et al. 2001). 
Ascorbic acid and  ce-tocopherol, free radical 
scavengers were also decreased, indicating the 
increase of oxidative stress of Alzheimer's disease 
(Tohgi et al. 1994; Schippling et al. 2000). 
 It is reported that the beta amyloid permeabil-
ity across cells was greater from the CSF-facing 
membrane than from the blood-facing membrane 
of CPECs. Similarly, cellular accumulation of beta 
amyloid was greater from the CSF-facing mem-
brane. This shows a bias for efflux. CP selec-
tively cleanses beta amyloid from the CSF by an 
undetermined mechanism, potentially reducing 
beta amyloid from normal brains and the brains of 
Alzheimer's disease patients (Crossgrove et al. 
2005). 
 Huntington's disease will be referred to below. 
 Concerning the detoxification of the CSF, CP 
contains a high concentration of glutathione, 
cysteine and methallothioneins, agents to seques-
ter toxic components by conjugating toxic agents 
in the CSF. The CP also contains superoxide 
dismutase, glutathione transferase, and reductase, 
enzymes to digest free radicals. In addition, it 
contains an organic ion transport system for 
exportation of noxious compounds from the CSF. 
 The above descriptions indicate that CPECs 
have critical influences on various aspects of 
functions for maintaining the CNS condition at the 
normal level.
 Transplantation of  encapsulated  OPECs
 As was described above, CPECs have neurotro-
phic effects on damaged CNS tissues when 
transplanted into the CSF or into the spinal cord 
in rats. The fact that, although they do not reach 
the injured site, CPECs transplanted into the CSF
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exert profound effects in CNS indicates that 
CPECs might release biologically active neurotro-
phic molecules into the CNS. This suggests that if 
CPECs are protected from immunological rejec-
tion, allogeneic or even xenogeneic transplanta-
tion of CPECs might be useful for clinical 
treatment. This thought leads to a new transplan-
tation method of CPECs, in which clusters of 
porcine CPECs are encapsulated in an alginate-
and poly-ornithine-coated capsule, and trans-
planted in the vicinity of the lesion in the CNS. 
This encapsulation protects CPECs from immuno-
logical reaction, while CPEC-secreted molecules 
can be released through the capsule into the 
surrounding tissue space (Skinner et al. 2009). 
 Thanos et al. (2007) showed the stability of 
conventional alginate formulation encapsulated 
using a commercially available technique and 
apparatus, which they describe as follows:  The 
microcapsules were produced, characterized, and 
implanted into the brain, peritoneal cavity and 
subcutaneous pace of rats. After 14-215 days, 
capsules were explanted and the surface was 
analyzed using Fourier-transform infrared spec-
troscopy and scanning electron microscopy. The 
surface morphology examined by these techni-
ques indicates that the encapsulated techniques 
and formulation produced a stable biocapsule 
capable of survival in all sites, including the harsh 
peritoneal environment for at least 215 days". 
 Encapsulated CPECs were transplanted into 
the ischemia-injured brain in rat. In the experi-
mental acute stroke occlusion of MCA for 1 h in a 
Wistar rat, encapsulated CPECs were trans-
planted immediately after occlusion in the pre-
dicted core of the cerebral infarction. Three days 
later, treated animals had better recovery of 
neurological function than did control animals, and 
the volume of the infarction was significantly 
decreased in the encapsulated CPEC-trans-
planted rats (Borlongan et al. 2004). They also 
showed that the conditioned medium of CP 
culture can rescue serum-deprived neurons 
cultured from rat embryonic brain cortex. 
 The effects of encapsulatedCPECs were 
examined in the experimental Huntington disease 
(Borlongan et al. 2004). In the abstract of the 
paper they report as follows:  "CP from neonatal 
pig was encapsulated in alginate microcapsule 
into the striatum. Three days later, the same 
animals received a unilateral injection of quino-
linic acid (225 nmol) into the site 2 mm from the 
transplant of the ipsilateral striatum. At an early 
stage, the GABAergic/encephalinergic projection 
to the external globus pallidus was preferentially
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affected. Cholinacetyltranspherase, substance P, 
cholecystokinin and angiotensin-converting en-
zyme were decreased. After surgery, animals 
were tested for motor function using the place-
ment test. Choroid plexus transplants amelio-
rated the weight loss and motor impairments 
resulting from quinolinic acid injection. Histo-
logical analysis  (Nissl staining) demonstrated that 
choroid plexus transplants significantly reduced 
the volume of striatum damage produced by 
quinolinic acid and protected choline acetyltrans-
ferase (ChaT) - but not NADPH-diaphorase-
positive  neurons." These studies imply that the 
transplantation of porcine CPECs can be used to 
protect striatal neurons from excitotoxic damage 
and that the pattern of neuroprotection varies 
across specific neuronal populations. 
 In the study of Huntington's disease using 
primates, Cynomolgus monkeys were trans-
planted with encapsulated porcine CPECs into the 
caudate and putamen. This is xenogeneic trans-
plantation. One week later, quinolinic acid was 
injected into the caudate and putamen. Stereo-
logical counts of NeuN-positive neurons showed 
that striatal neurons were distinctly protected by 
CPEC transplants, and that the striatal volume 
was well preserved (Emerich et al. 2006)
Stem cells in the CPECs
 Itokazu et al. (2006) reported that CPECs 
contain progenitor cells that can differentiate into 
neurons and glial cells. They reported as follows: 
 "Cell spheres were produced in the culture of the 
CP of the 4th ventricle of rats 1 day, 7 days and 8 
weeks after birth. Neurons (positive for  $tubulin 
class III), astrocytes (positive for GFAP) and 
oligodendrocytes (positive for 04) were differenti-
ated from the cell spheres in the differentiation 
 medium." Further they examined whether 
neuroprogenitor cells are contained in the CPECs. 
First, they produced a monoclonal antibody 3E6 
that specifically labels the microvilli of the CPECs. 
Using this monoclonal antibody, CPECs were 
isolated from the CP of postnatal-8-week rats by 
FACS (fluorescence-activated cell sorting). Im-
munohistochemistry confirmed that there was no 
contamination from fibroblasts, endothelial cells, 
macrophages, or Schwann cells in the FACS-
isolated cells. Cell spheres formed in the cultures 
of these 3E6-labeled CPECs. After expansion, 
these cell spheres gave rise to Tuj-1-( 5 %), GFAP-
(45%) and 04- positive cells (0.16%). The remain-
ing cells (45%) were unlabeled neural or glial 
markers. Some CPECs were immunohistochemi-
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cally stained with lineage-associated markers of 
Musashi-1 and epidermal growth factor-receptor 
(EGF-R). In addition, infusion of EGF of fibroblast 
growth factor-2 (FGF2) into the ventricle in-
creased the number of BrdU-positive (mitotic) 
cells among CPECs. This study shows that CP 
contains neuroprogenitor cells.
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